Ubamatamab (Synonyms: REGN4018)

Cat. No.: HY-P99539: FAQs
Data Sheet

Molarity Calculator

Ubamatamab (REGN4018) is a humanized bispecific antibody targeted against Mucin 16 (MUC16) and CD3. Ubamatamab demonstrates potent antitumor activity.

For research use only. We do not sell to patients.

Ubamatamab Chemical Structure

CAS No. : 2305629-50-7

Size		Stock
1 mg		Get quote	Estimated Time of Arrival: December 31
5 mg		Get quote	Estimated Time of Arrival: December 31

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Ubamatamab (REGN4018) is a humanized bispecific antibody targeted against Mucin 16 (MUC16) and CD3. Ubamatamab demonstrates potent antitumor activity^[1].

In Vitro

Ubamatamab (REGN4018; 0.1 pM-10 nM; 48 hours) induces human T cells and cynomolgus T cells to kill OVCAR-3 cells (EC50, 13.6 pM and 30.6 pM, respectively)^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:	OVCAR-3 cells
Concentration:	0.1 pM-10 nM
Incubation Time:	48 hours
Result:	Induced human T cells and cynomolgus T cells to kill OVCAR-3 cells.

In Vivo

Ubamatamab (REGN4018; 0.01-0.5 mg/kg; i.p; on days 6, 10, 13, 16, and 21) potently inhibits growth of intraperitoneal ovarian tumors^[1].
Ubamatamab (REGN4018; 0.01-1 mg/kg; i.p; once a week; total of five doses) shows minimal and transient increases in serum cytokines and C-reactive protein, with no overt toxicity^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	NOD SCID gamma (NSG) mice injected with OVCAR-3/Luc cells^[1]
Dosage:	0.01 mg/kg, 0.1 mg/kg, 0.5 mg/kg
Administration:	i.p; on days 6, 10, 13, 16, and 21
Result:	Significantly reduced tumor burden, and did not result in any changes in weight.

Animal Model:	Cynomolgus monkeys
Dosage:	0.01, 0.1, or 1 mg/kg
Administration:	i.p; once a week; total of five doses
Result:	Showed minimal and transient increases in serum cytokines and C-reactive protein.

Clinical Trial

CAS No.

2305629-50-7

SMILES

[Ubamatamab]

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Handling Instructions (2659 KB)

References

[1]. Alison Crawford, et al. A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer. Sci Transl Med. 2019 Jun 19;11(497):eaau7534. [Content Brief]

Ubamatamab Related Classifications

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Ubamatamab2305629-50-7REGN4018REGN 4018REGN-4018CD3Cluster of differentiation 3MUC16antitumor activity,Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Salutation

Applicant Name *

Email Address *

Phone Number *

Organization Name *

Department *

Requested quantity *

Country or Region *

Remarks